Skip to main content

November 2025

Advertisement for the Post of Student internship in SERB at SGPGIMS

Students in undergraduate engineering or postgraduate science e.g. M.Sc. / M.Tech (Biotechnology /Microbiology / Biochemistry / Life science or equivalent)
Walk in for M.Pharm, B.Pharm, MSc in Production, QC at SMS Pharmaceuticals
Hands-on experience in HPLC analysis of Raw Materials, Intermediates, and finished. API knowledge of Empower software preferred. Good documentation as per cGMP. Exposure to regulatory (US-FDA. EU-GMP) environments desirable
Hiring for Quality Control and Production at Rusan Pharma | B.Pharm, MSc, BSc Apply
Rusan is a research driven pharmaceutical company having its Manufacturing Units in India and Worldwide Marketing of Pharmaceutical Formulation, Active Pharmaceutical Ingredients and Intermediates.
Macleods Walk in Drive for M.Pharm, B.Pharm, MSc in Production Department
Experience in Operation Of Vial Filling & Sealing M/C With Crab, Autoclave/Tunnel/Vial Washing Operation With Ipc, Media Fill
Openings in QC, Packaging Development, Production at Centaur Pharma
To keep pace with our growth plan, we required young and energetic professionals for our Pune site, having experience in Formulation / Oral solid dosage.
Astron Hiring Production Officer - B.Pharm, BSc Apply
Supervise & train Production staff to ensure high performance & compliance with procedures. Evaluate employee performance & support overall employee development & conduct divisional trainings
Openings in Regulatory Affairs, Business Development, QC, QA at H&H Healthcare
H & H Healthcare and Cosmetics Pvt. Ltd. is involved in the manufacturing and supplying of  Nutraceutical, Pharmaceuticals, Syringe, Injection, Herbal and Cosmetics products.
Work as Scientific Writer at Merck Limited
A proven track record of successful scientific writing; comfortable with developing a range of content types concurrently and able to prioritize tasks to meet deadlines.
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz, the global leader in affordable medicines, today announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by Polpharma Biologics, TYRUKO® is the first and only US Food and Drug Administration (FDA) approved natalizumab biosimilar for the treatment of relapsing forms of multiple sclerosis (MS).
Lupin’s Nagpur Unit-1 Clears U.S. FDA Pre-Approval Inspection with No Observations
Global pharmaceutical company Lupin Limited announced today that the United States Food and Drug Administration (U.S. FDA) has successfully completed a product-specific pre-approval inspection at its Unit-1 oral solid dosage facility in Nagpur.